10.1016/j.neuropharm.2017.12.007 Neuropharmacology 72 ZhangH.ChuY.ZhengH.WangJ.SongB.SunY
From there, incorporate a nightly treatment with encapsulated retinol or retinaldehyde, paired with peptides, to support collagen and elasticity over time
Long-term human safety data not established
The comparison helps clarify what makes this medication unique
Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
A lower risk of microvascular problems is closely related with this magnitude of decrease, which is among the largest attained by any class of anti-diabetic drugs